02696.HK
Shanghai Henlius Biotech, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 70.10
+1.52%Next report
Analyst consensus
- Next report date
- Mar 19, 2027
- EPS estimate
- HKD 0.98
- Revenue estimate
- HKD 4.8B
Latest reported
- Last report date
- Aug 21, 2026
- EPS actual
- HKD 0.91
- EPS estimate
- HKD 0.50
- Revenue actual
- HKD 4.1B
- Revenue estimate
- HKD 3.9B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +83.8%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 19, 2027